Technical Analysis for AMPE - Ampio Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
C 1.82 -1.09% -0.02
AMPE closed down 1.09 percent on Friday, April 9, 2021, on 26 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical AMPE trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Inside Day Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Crossed Above 50 DMA Bullish -1.09%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -1.09%
Outside Day Range Expansion -1.09%
Fell Below 50 DMA Bearish 1.68%
Narrow Range Bar Range Contraction 1.68%
Older End-of-Day Signals for AMPE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 2 days ago
Fell Below 50 DMA 2 days ago
50 DMA Support 2 days ago
Down 2 % 2 days ago
Down 1% 2 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Ampio Pharmaceuticals, Inc. Description

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, together with its subsidiaries, engages in the discovery and development of pharmaceutical drugs and diagnostic products to identify, treat, and prevent metabolic disorders, eye diseases, kidney diseases, acute and chronic inflammation diseases, and male sexual dysfunction. Its products include Ampion, a non-steroidal anti-inflammatory biologic to treat inflammatory conditions and autoimmune diseases; Optina, an orally administered danazol for the treatment of diabetic macular edema; Vasaloc for the treatment of diabetic nephropathy; and Zertane, an oral drug for treating male sexual dysfunction to premature ejaculation, which is under Phase III clinical trial. The company is also developing a handheld oxidation-reduction potential diagnostic device for use at home or in healthcare facilities that will measure the oxidants/antioxidant balances in human blood and plasma; and methylphenidate derivatives for cancer, which are in pre-clinical development. Ampio Pharmaceuticals, Inc. is headquartered in Greenwood Village, Colorado.


Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Life Sciences Clinical Development Eye Diabetes Autoimmune Diseases Inflammation Autoimmune Disease Healthcare Facilities Dysfunction Kidney Disease Diagnostic Products Kidney Diseases Diabetic Retinopathy Macular Edema Eye Disease Diabetic Macular Edema Diabetic Nephropathy Metabolic Disorders Antioxidant Eye Diseases Methylphenidate Inflammatory Conditions Inflammation Diseases Male Sexual Dysfunction Sexual Dysfunction

Is AMPE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 2.98
52 Week Low 0.45
Average Volume 3,114,873
200-Day Moving Average 1.21
50-Day Moving Average 1.80
20-Day Moving Average 1.75
10-Day Moving Average 1.75
Average True Range 0.15
ADX 13.63
+DI 21.22
-DI 15.76
Chandelier Exit (Long, 3 ATRs ) 1.70
Chandelier Exit (Short, 3 ATRs ) 1.92
Upper Bollinger Band 1.93
Lower Bollinger Band 1.58
Percent B (%b) 0.69
BandWidth 20.13
MACD Line 0.02
MACD Signal Line 0.00
MACD Histogram 0.0184
Fundamentals Value
Market Cap 336.8 Million
Num Shares 185 Million
EPS 0.01
Price-to-Earnings (P/E) Ratio 130.00
Price-to-Sales 0.00
Price-to-Book 14.97
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.96
Resistance 3 (R3) 1.95 1.90 1.93
Resistance 2 (R2) 1.90 1.87 1.90 1.92
Resistance 1 (R1) 1.86 1.84 1.87 1.87 1.92
Pivot Point 1.81 1.81 1.81 1.81 1.81
Support 1 (S1) 1.77 1.78 1.78 1.78 1.72
Support 2 (S2) 1.72 1.75 1.72 1.72
Support 3 (S3) 1.68 1.72 1.71
Support 4 (S4) 1.69